Evidence map›Paper›PMID 39229038›Full record

ArticlebioRxiv : the preprint server for biology2024

Extracellular Vesicle-Associated Neutrophil Elastase Activates Hepatic Stellate Cells and Promotes Liver Fibrogenesis via ERK1/2 Pathway.

Regina Oshins, Zachary Greenberg, Yun-Ling Tai, Derrick Zhao, Xuan Wang, Borna Mehrad, Mei He, Ishan Patel, Laith Khartabil, Huiping Zhou and 2 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Regina OshinsDepartment of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine; University of Florida, Gainesville, Florida, USA.
Zachary GreenbergDepartment of Pharmaceutics, College of Pharmacy; University of Florida, Gainesville, Florida, USA.
Yun-Ling TaiDepartment of Microbiology and Immunology; Virginia Commonwealth University, Richmond VA Medical Center, Richmond, Virginia, USA.
Derrick ZhaoDepartment of Microbiology and Immunology; Virginia Commonwealth University, Richmond VA Medical Center, Richmond, Virginia, USA.
Xuan WangDepartment of Microbiology and Immunology; Virginia Commonwealth University, Richmond VA Medical Center, Richmond, Virginia, USA.
Borna MehradDepartment of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine; University of Florida, Gainesville, Florida, USA.ORCID 0000-0001-5198-065X
Mei HeDepartment of Pharmaceutics, College of Pharmacy; University of Florida, Gainesville, Florida, USA.
Ishan PatelDepartment of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine; University of Florida, Gainesville, Florida, USA.
Laith KhartabilDepartment of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine; University of Florida, Gainesville, Florida, USA.
Huiping ZhouDepartment of Microbiology and Immunology; Virginia Commonwealth University, Richmond VA Medical Center, Richmond, Virginia, USA.
Mark BrantlyDepartment of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine; University of Florida, Gainesville, Florida, USA.
Nazli KhodayariDepartment of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine; University of Florida, Gainesville, Florida, USA.

Funding

LncRNA H19 in Cholestatic Liver DiseasesR01DK115377 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI HYLEMON, PHILLIP B, ZHOU, HUIPING ROSE · 2018 to 2021
$2.1M
LncRNA H19 in Cholestatic Liver DiseasesR56DK115377 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI HYLEMON, PHILLIP B, ZHOU, HUIPING ROSE · 2023 to 2023
$630k
BLR&D Research Career Scientist Award ApplicationIK6BX004477 · VA · VA VETERANS ADMINISTRATION HOSPITAL · PI HUIPING ZHOU · 2019 to 2026
–
BLRD VA IK6 BX004477NIDDK NIH HHS R01 DK115377NIDDK NIH HHS R56 DK115377
6 · The paper itself

Abstract

Liver fibrosis associated with increased mortality is caused by activation of hepatic stellate cells and excessive production and accumulation of extracellular matrix in response to fibrotic insults. It has been shown that in addition to liver inflammation, systemic inflammation also contributes to liver fibrogenesis. A deeper understanding of mechanisms that control liver fibrotic response to intra- and extra-hepatic inflammation is essential to develop novel clinical strategies against this disease. Extracellular vesicles (EV) have been recognized as immune mediators that facilitate activation of hepatic stellate cells. In inflammatory diseases, activated neutrophils release neutrophil elastase (NE) bound to EV, which has been identified as a significant contributor to inflammation by promoting immune cell activation. Here, we aimed to explore the role of inflammation derived plasma EV-associated NE in liver fibrogenesis and its potential mechanisms. We show EV-associated NE induces activation, proliferation and migration of hepatic stellate cells by promoting activation of the ERK1/2 signaling pathway. This effect did not occur through EV without surface NE, and Sivelestat, a NE inhibitor, inhibited activation of the ERK1/2 signaling pathway mediated by EV-associated NE. Moreover, we found plasma EV-associated NE increases deposition of collagen1 and α-smooth muscle actin in the liver of a mouse model of liver fibrosis (Mdr2

Indexed as

Extracellular vesicleshepatic stellate cellsliver fibrosisneutrophil elastase

Identifiers

PMID39229038
PMCPMC11370372

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.